The Residential M.S. program in the Department of Pharmaceutical Outcomes & Policy is closely aligned with the Ph.D. program. Students admitted into this program follow the same core curriculum and when graduating, are well prepared to transition into a Ph.D. program if desired.
Contact Information Email: alaaalshehri.ufl.edu Curriculum Vitae Education King Faisal University, College of Clinical Pharmacy, Pharm.D degree, 2012-2017 Entry Date into the POP M.S. program: Fall 2021 Research Interests Pharmacoeconomic study Professional experience Working at Imam Abdullrahman Bin Faisal University from 26. September, 2018 till now as…
Please join us Thursday, 11/05/2020 for POP Research seminar of the Fall 2020, held from 11:00 am-12:30 pm in the Health Professions, Nursing, and Pharmacy Building Auditorium (Room HPNP 1404) or via Zoom. We will be welcoming, Amir Sarayani, Pharm.D., M.P.H. as our seminar speaker. Amir Sarayani completed…
Congratulations to Amir Sarayani, Thui Thai, and Juan Hincapie-Castillo for receiving awards for the best abstracts submitted by students / postdocs during the 35th International Conference on Pharmacoepidemiology in Philadelphia. There are hundreds of student abstracts submitted for presentation at the annual meeting and the top three get recognized…
Participating in the spring Ph.D. commencement ceremony were Wei Wang, Yan Li and Juan Hincapie-Castillo. Also graduating were M.S. students: Ching-Yu (Jessie) Wang and Fatimah Alyami.
The Department of Pharmaceutical Outcomes & Policy is proud to announce that Yan Li was the winner of the 2019 poster competition in the category of “Pain, Addiction, and CNS Disorders”, sponsored by Dr. David Wallace, ’91. The research project he presented was titled: Risk of Opioid Overdose Associated…
Dawwas was awarded an American Association of University Women international fellowship in 2017-18.
Our Ph.D. graduates Fall 2018: Monica Munoz, Pharm.D., M.S., Ph.D.; Ghadeer Dawwas, BS.Pharm., M.B.A., Ph.D.; Abdullah Alalwan, Pharm.D., Ph.D.; and Ju Hyeun (Elise) Kim, Pharm.D., Ph.D. They are pictured with advisors Abraham Hartzema, Pharm.D., MSPH, Ph.D., FISPE; Haesuk Park, Ph.D. and Almut Winterstein, RPh, Ph.D., FISPE
The study suggests that SGLT2 inhibitors are safe and effective in treatment of patients with type II diabetes.
ISPOR awarded Ghadeer Dawwas, M.B.A., BSPharm, a graduate student in the department of pharmaceutical outcomes and policy, the Best Student Poster Research.
